Group B Streptococcus (GBS) is an important perinatal pathogen. Because transplacentally acquired maternal antibodies to the GBS capsular polysaccharides (CPS) confer protection, prevention of infant disease may be possible after immunization of women. Unfortunately, the purified CPS of GBS are only variably immunogenic in adults; therefore to enhance immunogenicity we have designed and developed a CPS-protein conjugate vaccine. The lability of a conformationally dependent epitope on the III CPS containing a critical sialic acid residue was important to consider in vaccine design. 100 women were randomized to receive GBS type III CPS-tetanus toxoid conjugate (III-TT) vaccine at one of three doses; unconjugated GBS type III CPS; or saline. Serum samples were obtained before immunization and 2, 4, 8, and 26 wk thereafter, and specific antibody to type III CPS was measured. Vaccines were well tolerated. In sera from recipients of the highest dose of III-TT, CPS-specific IgG levels rose from a geometric mean of 0.09 microg/ml before immunization to 4.53 microg/ml 8 wk later, whereas levels in recipients of unconjugated type III CPS rose from 0.21 microg/ml to 1.41 microg/ml. Lower doses resulted in lower antibody levels. A > or = 4-fold rise in antibody concentration was achieved in 90% of recipients of III-TT compared with 50% of those that received III CPS (P = 0.0015). Antibodies evoked by the conjugate vaccine recognized a conformationally dependent epitope of the III-CPS, promoted opsonophagocytosis and killing of GBS, and, after maternal immunization, protected neonatal mice from lethal challenge with type III GBS. We conclude that directed coupling of type III GBS polysaccharide to a carrier protein yielded a conjugate vaccine with preserved expression of a highly labile conformational epitope involving sialic acid and enhanced immunogenicity compared with uncoupled CPS.
D L Kasper, L C Paoletti, M R Wessels, H K Guttormsen, V J Carey, H J Jennings, C J Baker
Title and authors | Publication | Year |
---|---|---|
Potency of clinical group B streptococcal conjugate vaccines
LC Paoletti |
Vaccine | 2001 |
Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate
X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, G Wallerström, J Holmgren |
Vaccine | 2001 |
Impairment of Type III Group B Streptococcus-Stimulated Superoxide Production and Opsonophagocytosis by Neutrophils in Diabetes
MA Mazade, MS Edwards |
Molecular Genetics and Metabolism | 2001 |
Initial Studies of the Molecular Basis of Peptide Mimicry of Group B Streptococcal Type III Capsular Polysaccharide
SH Pincus, SR Lepage, RF Jung, JG Massey, M Jaseja |
International Reviews of Immunology | 2001 |
Anti-idiotypic Vaccination against Group B Streptococci
C Beninati, M Oggioni, G Mancuso, A Midiri, L Polonelli, G Pozzi, G Teti |
International Reviews of Immunology | 2001 |
Vaccines in Pregnancy
FM Munoz, JA Englund |
Infectious Disease Clinics of North America | 2001 |
Modulation of the complement system in the prevention and treatment of sepsis
E Andrews, PA Feldhoff, HA Lassiter |
Seminars in Pediatric Infectious Diseases | 2001 |
Maternal vaccines
WP Glezen |
Primary Care Clinics in Office Practice | 2001 |
The Molecular Immunology of Complex Carbohydrates —2
AM Wu |
2001 | |
Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines
EI Tuomanen, LC Paoletti, MA Rench, DL Kasper, D Molrine, D Ambrosino, CJ Baker |
Infection and immunity | 2001 |
Group B Streptococcus Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccines Prepared by Different Methods for Intranasal Immunization
EI Tuomanen, X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, J Holmgren |
Infection and immunity | 2001 |
Localization of Surface Immunogenic Protein on Group B Streptococcus
EI Tuomanen, S Rioux, D Martin, HW Ackermann, J Dumont, J Hamel, BR Brodeur |
Infection and immunity | 2001 |